Estrogen and Mast Cells
Mast cells are the immune cells most people think of when they think of allergies. They sit in your skin, your airways, your gut, and your blood vessel walls, and when they're triggered, they release histamine and other mediators that produce the familiar symptoms of an allergic reaction — itching, swelling, flushing, congestion, wheezing.
Mast cells also have estrogen receptors. A widely cited mini-review in Frontiers in Immunology describes how estradiol can act on estrogen receptor-α on the mast cell surface, trigger a rapid influx of calcium into the cell, and lower the threshold at which the cell releases its mediators — sometimes even without an allergen present. In plain language: when estradiol is doing certain things, mast cells become quicker to fire.
This is part of why allergic disease shows a strong female pattern from puberty onward. Before puberty, asthma is more common in boys; after puberty, asthma and many other allergic conditions become more common in women. Reviews of sex hormones and allergy describe the same pattern across allergic rhinitis, eczema, chronic hives, drug reactions, and anaphylaxis.
Perimenopause adds a specific twist. Estradiol in the perimenopausal transition doesn't fall in a straight line. It fluctuates — sometimes higher than it was in earlier reproductive years, sometimes lower, often unpredictably from one cycle to the next, as described by The Menopause Society. Those swings, more than the eventual decline, appear to be what destabilizes the system. Mast cells get noisier when the hormonal weather changes day to day.
Progesterone, Cytokines, and Histamine Clearance
Estradiol gets most of the attention in menopause coverage, but progesterone is the quieter half of this story. At physiologic doses, progesterone has anti-inflammatory effects on smooth muscle and airway tissue and can help stabilize mast cells. It also falls earlier and more steeply than estrogen in the perimenopausal transition, which means one of the immune system's natural brakes loosens before the other one does.
A 2026 review in Frontiers in Allergy synthesizes the broader picture: declining and fluctuating estrogen and progesterone modulate mast cell activity, vascular permeability, and type 2 inflammation, contributing to distinct phenotypes in asthma, allergic rhinitis, chronic cough, skin allergies, drug hypersensitivity, anaphylaxis, and angioedema. Alongside those mast cell effects, perimenopause is associated with a more pro-inflammatory baseline — modestly elevated IL-6, TNF-α, and IL-1β compared with premenopausal levels — and a Th1/Th2 balance that tilts toward the allergy-prone Th2 side.
There's one more piece worth knowing about: diamine oxidase, or DAO, the enzyme that clears histamine from foods in the gut. DAO activity varies across the menstrual cycle and across reproductive life, which is part of why some women notice that histamine-rich foods — red wine, aged cheese, fermented foods, leftovers — bother them in ways they never used to. The Cleveland Clinic is careful to note that "histamine intolerance" as a stand-alone diagnosis is still debated, and that more recent research has ruled it out in many people who suspected it. The experience is real; the label is still a moving target.